JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB109450

Anti-Glutamate Receptor 1 (AMPA subtype) 抗体 [EPR5479]

Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479]

5

(2 Reviews)

|

(72 Publications)

Rabbit Recombinant Monoclonal Glutamate Receptor 1 (AMPA subtype) antibody. Suitable for IP, WB and reacts with Mouse, Rat, Human samples. Cited in 72 publications.

查看别名

GLUA1, GLUH1, GLUR1, GRIA1, Glutamate receptor 1, GluR-1, AMPA-selective glutamate receptor 1, GluR-A, GluR-K1

5 Images
Immunoprecipitation - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (AB109450)
  • IP

Unknown

Immunoprecipitation - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (AB109450)

ab109450 (purified) at 1/20 immunoprecipitating Glutamate Receptor 1 in Mouse Brain whole cell lysate. 10 ug of cell lysate was present in the input. For western blotting, a HRP-conjugated Veriblot for IP Detection Reagent (ab131366) (1/1,500) was used for detection. A rabbit monoclonal IgG (ab172730) was used intead of ab128913 as a negative control (Lane 3).

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Immunoprecipitation - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (ab109450)

Predicted band size: 102 kDa

false

Western blot - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (AB109450)
  • WB

Lab

Western blot - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (AB109450)

Exposure times :

Lanes 1 and 2 : 180 seconds
Lanes 3 and 4 : 50 seconds
Lanes 5 and 6 : 60 seconds

We recommend to use 1%SDS Hot lysis prepare method to get desired Western Blot results.

All lanes:

Western blot - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (ab109450) at 1/2000 dilution

Lane 1:

Human brain lysates prepared in RIPA lysis method at 20 µg

Lane 2:

Human brain lysates prepared in 1%SDS Hot lysis method at 20 µg

Lane 3:

Rat brain lysates prepared in RIPA lysis method at 20 µg

Lane 4:

Rat brain lysates prepared in 1%SDS Hot lysis method at 20 µg

Lane 5:

Mouse brain lysates prepared in RIPA lysis method at 20 µg

Lane 6:

Mouse brain lysates prepared in 1%SDS Hot lysis method at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 102 kDa

Observed band size: 102 kDa

false

Western blot - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (AB109450)
  • WB

Unknown

Western blot - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (AB109450)

All lanes:

Western blot - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (ab109450) at 1/1000 dilution

Lane 1:

Human brain lysate at 10 µg

Lane 2:

Mouse brain lysate at 10 µg

Lane 3:

Rat brain lysate at 10 µg

Predicted band size: 102 kDa

Observed band size: 106 kDa

false

OI-RD Scanning - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (AB109450)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (AB109450)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

Western blot - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (AB109450)
  • WB

CiteAb

Western blot - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (AB109450)

Glutamate Receptor 1 (AMPA subtype) western blot using anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] ab109450. Publication image and figure legend from Luo, Y. X., Xue, Y. X., et al., 2015, Nat Commun, PubMed 26169171.

ab109450 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab109450 please see the product overview.

Exposure to UCS decreased membrane expression of GluA1 and GluA2 in BLA.(a) Timeline of the experimental procedure. (b) Membrane expression of GluA1 and GluA2 proteins after the different experiment manipulations. Values are the mean percentage of protein levels in the BLA in reference to the saline+1 h+extinction group. One-way ANOVA, *Different from group 'saline+1 h+extinction', *P<0.05; n=6 per experimental condition. Error bars represent s.e.m. Uncropped western blots of the data depicted in Fig. 5 are provided in Supplementary Fig. 10.

false

不同偶联物与剂型 (1)

  • Carrier free

    Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] - BSA and Azide free

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR5479

亚型

IgG

不含载体蛋白

No

反应种属

Mouse, Rat, Human

应用

IP, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p><strong>For unpurified use at 1/10000 - 1/50000.</strong></p><p>We recommend to use 1%SDS Hot lysis prepare method to get desired Western Blot results.</p><p>For Lysate preparation protocol, please refer to the protocol book in the protocol section and/or <a data-tabindex-counter=\"1\" data-tabindex-value=\"none\" href=\"../../technical-resources/protocols/lysate-preparation-for-western-blot\" tabindex=\"-1\">here.</a></p>" }, "Mouse": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p><strong>For unpurified use at 1/10000 - 1/50000.</strong></p><p>We recommend to use 1%SDS Hot lysis prepare method to get desired Western Blot results.</p><p>For Lysate preparation protocol, please refer to the protocol book in the protocol section and/or <a data-tabindex-counter=\"1\" data-tabindex-value=\"none\" href=\"../../technical-resources/protocols/lysate-preparation-for-western-blot\" tabindex=\"-1\">here.</a></p>" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p><strong>For unpurified use at 1/10000 - 1/50000.</strong></p><p>We recommend to use 1%SDS Hot lysis prepare method to get desired Western Blot results.</p><p>For Lysate preparation protocol, please refer to the protocol book in the protocol section and/or <a data-tabindex-counter=\"1\" data-tabindex-value=\"none\" href=\"../../technical-resources/protocols/lysate-preparation-for-western-blot\" tabindex=\"-1\">here.</a></p>" } } }

产品详情

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Stable for 12 months at -20°C

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

Glutamate Receptor 1 (AMPA subtype) also known as GluR1 is a subunit of the AMPA receptor complex which mediates fast synaptic transmission in the central nervous system. It is an ionotropic receptor for glutamate functioning by opening ion channels to allow the flow of Na+ and Ca2+ ions across the cell membrane contributing to excitatory neurotransmission. The GluR1 subunit has a molecular mass of approximately 100 kDa. This receptor is commonly expressed in the brain regions such as the hippocampus and the cerebral cortex playing an important role in synaptic plasticity and memory formation.
Biological function summary

The GluR1 subunit is an essential component of the AMPA receptor complex which typically forms as a tetramer. This complex modulates synaptic strength and plasticity processes critical for learning and memory. The activity of AMPA receptors including those containing GluR1 is regulated by several auxiliary proteins and is essential for post-synaptic responses. The GluR1 subunit also interacts with other proteins such as TARPs which modulate its trafficking and channel properties.

Pathways

The GluR1-containing AMPA receptors participate significantly in the glutamatergic signaling pathway which is vital for fast excitatory synaptic transmission in the brain. This pathway also involves the NMDA receptors which work together with AMPA receptors to regulate synaptic plasticity and neuronal communication. Additionally the GluR1 interacts within the long-term potentiation (LTP) pathway contributing to the strengthening of synapses an essential mechanism underlying learning and memory.

Dysfunction in GluR1 and associated AMPA receptors has been implicated in conditions like Alzheimer's disease and epilepsy. Alzheimer's disease exhibits decreased synaptic transmission and plasticity linked to impaired GluR1 function and its interactions with NMDA receptors. In epilepsy abnormal GluR1 activity may contribute to heightened neuronal excitability and seizure propagation. Targeting GluR1 or associated pathways offers potential for therapeutic interventions in these disorders possibly through drugs such as memantine and NBQX which modulate receptor activity.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Ionotropic glutamate receptor that functions as a ligand-gated cation channel, gated by L-glutamate and glutamatergic agonists such as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), quisqualic acid, and kainic acid (PubMed : 1311100, PubMed : 20805473, PubMed : 21172611, PubMed : 28628100, PubMed : 35675825). L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse upon entry of monovalent and divalent cations such as sodium and calcium. The receptor then desensitizes rapidly and enters in a transient inactive state, characterized by the presence of bound agonist (By similarity). In the presence of CACNG2 or CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of L-glutamate (PubMed : 21172611). Resensitization is blocked by CNIH2 through interaction with CACNG8 in the CACNG8-containing AMPA receptors complex (PubMed : 21172611). Calcium (Ca(2+)) permeability depends on subunits composition and, heteromeric channels containing edited GRIA2 subunit are calcium-impermeable. Also permeable to other divalents cations such as strontium(2+) and magnesium(2+) and monovalent cations such as potassium(1+) and lithium(1+) (By similarity).
See full target information GRIA1

文献 (72)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 26: PubMed41009625

2025

Fenofibrate as a PPARα Agonist Modulates Neuroinflammation and Glutamate Receptors in a Rat Model of Temporal Lobe Epilepsy: Region-Specific Effects and Behavioral Outcomes.

Applications

Unspecified application

Species

Unspecified reactive species

Anna A Kovalenko,Maria V Zakharova,Olga E Zubareva,Alexander P Schwarz,Yury A Skorik,Aleksey V Zaitsev

Nature aging 5:1957-1969 PubMed40830655

2025

Targeting iron-associated protein Ftl1 in the brain of old mice improves age-related cognitive impairment.

Applications

Unspecified application

Species

Unspecified reactive species

Laura Remesal,Juliana Sucharov-Costa,Yuting Wu,Karishma J B Pratt,Gregor Bieri,Amber Philp,Mason Phan,Turan Aghayev,Charles W White,Elizabeth G Wheatley,Bende Zou,Brandon R Desousa,Julien Couthouis,Isha H Jian,Xinmin S Xie,Yi Lu,Jason C Maynard,Alma L Burlingame,Saul A Villeda

Molecular psychiatry : PubMed40796696

2025

Cadherin 11 regulates presynaptic vesicle trafficking and neuronal activity in autism-related brain circuit.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoxiao Cao,Jingyan Jia,Ze Li,Simeng Guo,Jiale Duan,Ji Ma,Xiao-Bing Yuan,Yi-Hsuan Pan

Frontiers in molecular neuroscience 18:1635852 PubMed40771360

2025

Chronic reduction of synaptic proteins in the epileptogenic lesion of patients with hippocampal sclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Akiko Oota-Ishigaki,Nami Suzuki,Keiya Iijima,Yutaro Takayama,Yuiko Kimura,Kotaro Hattori,Masaki Iwasaki,Takashi Hayashi

Addiction neuroscience 15: PubMed40575352

2025

EcoHIV infection effects on cocaine seeking and neuroimmune responses in male mice depend on cocaine exposure pattern.

Applications

Unspecified application

Species

Unspecified reactive species

Mark D Namba,Qiaowei Xie,Kyewon Park,Joshua G Jackson,Jacqueline M Barker

Autophagy 21:807-826 PubMed39635882

2024

Upregulation of ISG15 induced by MAPT/tau accumulation represses autophagic flux by inhibiting HDAC6 activity: a vicious cycle in Alzheimer disease.

Applications

Unspecified application

Species

Unspecified reactive species

Qian Liu,Xin Wang,Zhi-Ting Fang,Jun-Ning Zhao,Xue-Xiang Rui,Bing-Ge Zhang,Ye He,Rui-Juan Liu,Jian Chen,Gao-Shang Chai,Gong-Ping Liu

Research (Washington, D.C.) 7:0482 PubMed39301264

2024

Gut Microbiota-Metabolite-Brain Axis Reconstitution Reverses Sevoflurane-Induced Social and Synaptic Deficits in Neonatal Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Youyi Zhao,Sanxing Ma,Lirong Liang,Shuhui Cao,Ze Fan,Danyi He,Xiaotong Shi,Yao Zhang,Bing Liu,Meiting Zhai,Shengxi Wu,Fang Kuang,Hui Zhang

Molecular psychiatry 30:435-449 PubMed39097664

2024

Rasd2 regulates depression-like behaviors via DRD2 neurons in the prelimbic cortex afferent to nucleus accumbens core circuit.

Applications

Unspecified application

Species

Unspecified reactive species

Ziqian Cheng,Fangyi Zhao,Jingjing Piao,Wei Yang,Ranji Cui,Bingjin Li

Nature chemical biology 21:109-119 PubMed39090312

2024

Photoproximity labeling of endogenous receptors in the live mouse brain in minutes.

Applications

Unspecified application

Species

Unspecified reactive species

Mikiko Takato,Seiji Sakamoto,Hiroshi Nonaka,Fátima Yuri Tanimura Valor,Tomonori Tamura,Itaru Hamachi

Frontiers in cellular neuroscience 18:1366098 PubMed38644975

2024

Micro-and mesoscale aspects of neurodegeneration in engineered human neural networks carrying the LRRK2 G2019S mutation.

Applications

Unspecified application

Species

Unspecified reactive species

Vibeke Devold Valderhaug,Ola Huse Ramstad,Rosanne van de Wijdeven,Kristine Heiney,Stefano Nichele,Axel Sandvig,Ioanna Sandvig
View all publications
websiteProtocolBooklet
en

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com